Activity Tracking for Type 2 Diabetes

This trial aims to determine how people over 55 with type 2 diabetes can use a continuous glucose monitor (CGM) and activity tracker to improve their health. The focus is on reducing sedentary time and enhancing blood sugar control. Participants will track their activity and receive reminders about sedentary behavior over 40 days as part of the SB Intervention, a behavioral intervention. Individuals who have had type 2 diabetes for at least five years, can speak and read English, and do not have severe conditions like lung disease or heart failure may be suitable for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance diabetes management for many.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Previous studies found that people with type 2 diabetes who joined programs like the SB Intervention increased their physical activity without serious side effects. Research has shown that these programs can help individuals become more active and manage their diabetes more effectively. Importantly, no major health problems were reported, suggesting the program is generally safe. Participants in similar programs did not experience significant negative health effects.¹²³⁴⁵

Unlike traditional treatments for type 2 diabetes that often rely on medication or lifestyle changes like diet and exercise, the SB Intervention is unique because it focuses on self-monitoring and reducing sedentary behavior. By incorporating a 10-day period of self-monitoring and reminders, followed by 30 days of activity tracking, this approach emphasizes behavior modification through increased awareness and accountability. Researchers are excited about this trial because it explores the potential of technology to empower individuals to actively manage their condition in a more personalized and sustainable way, potentially reducing reliance on medications.

Research has shown that excessive sitting or lying down can harm people with type 2 diabetes. This trial will evaluate the SB Intervention, which includes 10 days of self-monitoring and reminders about sedentary behavior, followed by 30 days of activity monitoring. One study found that a program encouraging more movement helped people with type 2 diabetes become more active and sit less. Additionally, a review demonstrated that lifestyle changes, such as using fitness trackers, significantly increased daily steps, aiding in blood sugar control. Digital tools that track activity have also proven effective in encouraging more movement and less sitting. Overall, these findings suggest that reducing sedentary behavior can help manage type 2 diabetes by improving activity levels and blood sugar control.⁶⁷⁸⁹¹⁰